Natural history of liver disease in cystic fibrosis

Hepatology

Volumn 30, Issue 5, 1999, Pages 1151-1158

  Lindblad, Anders ^a   Glaumann, Hans ^b   Strandvik, Birgitta ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CYSTIC FIBROSIS; DISEASE COURSE; ECHOGRAPHY; ESSENTIAL FATTY ACID DEFICIENCY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; STEATOSIS;

ADOLESCENT; ADULT; BIOPSY; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DISEASE PROGRESSION; FATTY ACIDS, ESSENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PUBERTY; RISK FACTORS;

EID: 0032753456     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300527     Document Type: Article

References (17)

1. Scott-Jupp R, Lama M, Tanner MS. Prevalence of liver disease in cystic fibrosis. Arch Dis Child 1991;66:698-701.
2. Feigelson J, Anagnostopoulos C, Poquet M, Pecau Y, Munck A, Navarro J. Liver cirrhosis in cystic fibrosis-therapeutic implications and long term follow up. Arch Dis Child 1993;68:653-657.
3. Duthie A, Doherty DG, Williams C, Scott-Jupp R, Warner JO, Tanner MS, Williamson R, et al. Genotype analysis for delta F508, G551D and R553X mutations in children and young adults with cystic fibrosis with and without chronic liver disease. HEPATOLOGY 1992;15:660-664.
4. O'Brien S, Mulcahy H, Fenlon H, O'Broin A, Casey M, Burke A, FitzGerald MX, et al. Intestinal bile acid malabsorption in cystic fibrosis. Gut 1993;34:1137-1141.
5. Lindblad A, Hultcrantz R, Strandvik B. High doses of aminoglycosides did not produce liver toxicity in patients with cystic Fibrosis. J Hepatol 1994;20:201-205.
6. Colombo C, Apostolo MG, Ferrari M, Seia M, Genoni S, Giunta A, Sereni LP. Analysis of risk factors for the development of liver disease associated with cystic fibrosis. J Pediatr 1994;124:393-399.
7. Lindblad A, Diczfalusy U, Hultcrantz R, Thorell A, Strandvik B. Vitamin A concentration in the liver decreases with age in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 1997;24:264-270.
8. Gaskin KJ, Waters DL, Howman-Giles R, de Silva M, Earl JW, Martin HC, Kan AE, et al. Liver disease and common-bile-duct stenosis in cystic fibrosis. N Engl J Med 1988;318:340-346.
9. Maurage C, Lenaerts C, Weber A, Brochu P, Yousef I, Roy CC. Meconium ileus and its equivalent as a risk factor for the development of cirrhosis: an autopsy study in cystic fibrosis. J Pediatr Gastroenterol Nutr 1989;9:17-20.
10. O'Brien S, Keogan M, Casey M, Duffy G, McErlean D, Fitzgerald MX, Hegarty JE. Biliary complications of cystic fibrosis. Gut 1992;33:387-391.
11. Lindblad A, Strandvik B, Hjelte L. Incidence of liver disease in patients with cystic fibrosis and meconium ileus. J Pediatr 1995;126:155-156.
12. Psacharopoulos HT, Howard ER, Portmann B, Mowat AP, Williams R. Hepatic complications of cystic fibrosis. Lancet 1981;2:78-80.
13. Strandvik B. Antibiotic therapy of pulmonary infections in cystic fibrosis. Chest 1988;94:146S-148S.
14. Strandvik B, Hjelte L, Malmborg AS, Widen B. Home intravenous antibiotic treatment of patients with cystic fibrosis. Acta Paediatr 1992;81:340-344.
15. Kusoffsky E, Strandvik B, Troell S. Prospective study of fatty acid supplementation over 3 years in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 1983;2:434-438.
16. Arborgh B, Eklund A, Norman A, Strandvik B. Urinary bile acid excretion in correlation to liver histopathology in cystic fibrosis. Scand J Gastroenterol 1980;15:73-80.
17. Strandvik B, Samuelson K. Fasting serum bile acid levels in relation to liver histopathology in cystic fibrosis. Scand J Gastroenterol 1985;20:381-384.